Get the Stockscreener App
3.81
1.74%
0.07
Orchestra Biomed Holdings Inc stock is traded at $3.81, with a volume of 13,827.
It is up +1.74% in the last 24 hours and down -10.26% over the past month.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
See More
Previous Close:
$3.74
Open:
$3.8
24h Volume:
13,827
Relative Volume:
0.04
Market Cap:
$226.95M
Revenue:
$32.72M
Net Income/Loss:
$-54.64M
P/E Ratio:
-3.3786
EPS:
-1.1277
Net Cash Flow:
$-55.08M
1W Performance:
+2.56%
1M Performance:
-10.26%
6M Performance:
-8.53%
1Y Performance:
+15.65%
1-Day Range:
$3.75
$3.84
1-Week Range:
$3.555
$3.84
52-Week Range:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.79 | 223.95M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
484.98 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
673.35 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
908.04 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.75 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Initiated | TD Cowen | Buy |
| Aug-20-25 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Orchestra Biomed Holdings Inc - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orchestra BioMed Hldgs Market Sentiment - Benzinga
TradingKey - TradingKey
OBIO|Orchestra Biomed Holdings Inc|Price:3.740|Chg%:+0.100 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts (NASDAQ:OBIO) - Seeking Alpha
Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO - TradingView
OBIOOrchestra BioMed Holdings Inc Latest SEC Filings - Finviz
Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates - Kalkine
Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi - GuruFocus
Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan - Stock Titan
Form 144 Orchestra BioMed Holdings For: 1 July By Investing.com - Investing.com South Africa
Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO) - Stock Titan
Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes - marketscreener.com
Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying - simplywall.st
Orchestra Biomed Joins Russell 3000® and Russ - Moomoo
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index - marketscreener.com
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2500 Growth Benchmark - marketscreener.com
Orchestra BioMed stock rises after Russell index addition By Investing.com - Investing.com Australia
Orchestra BioMed stock rises after Russell index addition - Investing.com
Orchestra BioMed (OBIO) Joins Russell 3000 and Russell 2000 Inde - GuruFocus
Orchestra BioMed joins Russell 2000 and 3000 indexes - Investing.com
Orchestra BioMed joins Russell 2000 and 3000 indexes By Investing.com - Investing.com Australia
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark - marketscreener.com
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 3000 Growth Benchmark - marketscreener.com
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 3000E Index - marketscreener.com
Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO) - TradingView
Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com - Investing.com Nigeria
OBIO Forecast — Price Target — Prediction for 2027 - TradingView
Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld - Stock Titan
Orchestra BioMed (OBIO) director awarded RSUs and options with tax-share withholding - Stock Titan
Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants - Stock Titan
Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike - Stock Titan
Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes - Stock Titan
Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com - Investing.com India
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting By Investing.com - Investing.com Australia
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting - Investing.com South Africa
Orchestra BioMed Shareholders Approve Directors and Incentive Plan - TipRanks
Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items - Stock Titan
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):